Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 276Precursor Cell Lymphoblastic Leukemia-Lymphoma 55Recurrence 43Neoplasms, Plasma Cell 32Leukemia 29Lymphoma 25Neoplasms 23Vomiting 21Burkitt Lymphoma 20Lymphoma, Non-Hodgkin 19Nausea 17Immunoglobulin Light-chain Amyloidosis 17Lymphoma, Mantle-Cell 16Carcinoma, Non-Small-Cell Lung 15Prostatic Neoplasms 14Waldenstrom Macroglobulinemia 13Lymphoma, Follicular 13Breast Neoplasms 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myeloid, Acute 10Lymphoma, B-Cell, Marginal Zone 9Amyloidosis 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Neoplasm Metastasis 7Hematologic Neoplasms 7Smoldering Multiple Myeloma 6Ovarian Neoplasms 6Lung Neoplasms 6

Interventions

Octreotide 2Rocuronium 1Metoclopramide 1Methylprednisolone 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Intestinal Obstruction × Dexamethasone × Clear all
NCT04027348 2022-11-29

Palliative Management of Inoperable Malignant Bowel Obstruction

Roswell Park Cancer Institute

Phase 2 Terminated
15 enrolled 10 charts

Intestinal Obstruction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡